Verenium Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
111
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$62M
Verenium General Information
Description
Developer of enzymes designed for use in industrial processes. The company extracts microbial DNA directly from collected samples to avoid the slow and often impossible task of growing microbes in the lab to identify unique enzymes as product candidates tailored for multiple sectors, including the global food and fuel markets.
Contact Information
Website
www.verenium.comCorporate Office
- 3550 John Hopkins Court
- San Diego, CA 92121
- United States
Corporate Office
- 3550 John Hopkins Court
- San Diego, CA 92121
- United States
Verenium Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 01-Sep-2013 | $62M | Completed | Generating Revenue | ||
| 5. Mezzanine | 01-Dec-2012 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 15-Jul-2010 | Completed | Generating Revenue | |||
| 3. IPO | 14-Feb-2000 | Completed | Generating Revenue | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Verenium Comparisons
Industry
Financing
Details
Verenium Competitors (9)
One of Verenium’s 9 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amyris (Biotechnology) | Private Equity-Backed | Emeryville, CA | ||||
| c-LEcta | Formerly PE-Backed | Leipzig, Germany | ||||
| Actylis | Private Equity-Backed | Port Washington, NY | ||||
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Conagen | Corporate Backed or Acquired | Bedford, MA |
Verenium Signals
Verenium Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Athyrium Capital Management | Asset Manager | Minority | ||
| Axiom Venture Partners | Venture Capital | Minority | ||
| BP | Corporation | Majority | ||
| Braemar Energy Ventures | Venture Capital | Minority | ||
| CRV | Venture Capital | Minority |
Verenium Investments & Acquisitions (2)
Verenium’s most recent deal was a Joint Venture with BP Verenium Biofuels. The deal was made on 18-Feb-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BP Verenium Biofuels | 18-Feb-2009 | Joint Venture | Buildings and Property | ||
| Celunol | 20-Jun-2007 | Merger/Acquisition | Industrial Chemicals |
Verenium FAQs
-
When was Verenium founded?
Verenium was founded in 1992.
-
Where is Verenium headquartered?
Verenium is headquartered in San Diego, CA.
-
What is the size of Verenium?
Verenium has 111 total employees.
-
What industry is Verenium in?
Verenium’s primary industry is Biotechnology.
-
Is Verenium a private or public company?
Verenium is a Private company.
-
What is the current valuation of Verenium?
The current valuation of Verenium is .
-
What is Verenium’s current revenue?
The current revenue for Verenium is .
-
How much funding has Verenium raised over time?
Verenium has raised $22.5M.
-
Who are Verenium’s investors?
Athyrium Capital Management, Axiom Venture Partners, BP, Braemar Energy Ventures, and CRV are 5 of 9 investors who have invested in Verenium.
-
Who are Verenium’s competitors?
Amyris (Biotechnology), c-LEcta, Actylis, Arzeda, and Conagen are some of the 9 competitors of Verenium.
-
When was Verenium acquired?
Verenium was acquired on 01-Sep-2013.
-
Who acquired Verenium?
Verenium was acquired by BASF.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process